209 related articles for article (PubMed ID: 18550891)
1. The AAA-ATPase p97 facilitates degradation of apolipoprotein B by the ubiquitin-proteasome pathway.
Fisher EA; Lapierre LR; Junkins RD; McLeod RS
J Lipid Res; 2008 Oct; 49(10):2149-60. PubMed ID: 18550891
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitination regulates the assembly of VLDL in HepG2 cells and is the committing step of the apoB-100 ERAD pathway.
Fisher EA; Khanna NA; McLeod RS
J Lipid Res; 2011 Jun; 52(6):1170-1180. PubMed ID: 21421992
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms targeting apolipoprotein B100 to proteasomal degradation: evidence that degradation is initiated by BiP binding at the N terminus and the formation of a p97 complex at the C terminus.
Rutledge AC; Qiu W; Zhang R; Kohen-Avramoglu R; Nemat-Gorgani N; Adeli K
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):579-85. PubMed ID: 19164805
[TBL] [Abstract][Full Text] [Related]
4. Liver cytochrome P450 3A endoplasmic reticulum-associated degradation: a major role for the p97 AAA ATPase in cytochrome P450 3A extraction into the cytosol.
Acharya P; Liao M; Engel JC; Correia MA
J Biol Chem; 2011 Feb; 286(5):3815-28. PubMed ID: 21107009
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-dependent and -independent proteasomal degradation of apoB associated with endoplasmic reticulum and Golgi apparatus, respectively, in HepG2 cells.
Liao W; Chang BH; Mancini M; Chan L
J Cell Biochem; 2003 Aug; 89(5):1019-29. PubMed ID: 12874835
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of p97-dependent protein degradation by Eeyarestatin I.
Wang Q; Li L; Ye Y
J Biol Chem; 2008 Mar; 283(12):7445-54. PubMed ID: 18199748
[TBL] [Abstract][Full Text] [Related]
7. AAA ATPase p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation.
Zhong X; Shen Y; Ballar P; Apostolou A; Agami R; Fang S
J Biol Chem; 2004 Oct; 279(44):45676-84. PubMed ID: 15331598
[TBL] [Abstract][Full Text] [Related]
8. Mouse Mammary Tumor Virus Signal Peptide Uses a Novel p97-Dependent and Derlin-Independent Retrotranslocation Mechanism To Escape Proteasomal Degradation.
Byun H; Das P; Yu H; Aleman A; Lozano MM; Matouschek A; Dudley JP
mBio; 2017 Mar; 8(2):. PubMed ID: 28351922
[TBL] [Abstract][Full Text] [Related]
9. Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains.
Ye Y; Meyer HH; Rapoport TA
J Cell Biol; 2003 Jul; 162(1):71-84. PubMed ID: 12847084
[TBL] [Abstract][Full Text] [Related]
10. The UBX protein SAKS1 negatively regulates endoplasmic reticulum-associated degradation and p97-dependent degradation.
LaLonde DP; Bretscher A
J Biol Chem; 2011 Feb; 286(6):4892-901. PubMed ID: 21135095
[TBL] [Abstract][Full Text] [Related]
11. Quality control: linking retrotranslocation and degradation.
Stirling CJ; Lord JM
Curr Biol; 2006 Dec; 16(24):R1035-7. PubMed ID: 17174911
[TBL] [Abstract][Full Text] [Related]
12. Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum.
Liao W; Yeung SC; Chan L
J Biol Chem; 1998 Oct; 273(42):27225-30. PubMed ID: 9765244
[TBL] [Abstract][Full Text] [Related]
13. Sequential actions of the AAA-ATPase valosin-containing protein (VCP)/p97 and the proteasome 19 S regulatory particle in sterol-accelerated, endoplasmic reticulum (ER)-associated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Morris LL; Hartman IZ; Jun DJ; Seemann J; DeBose-Boyd RA
J Biol Chem; 2014 Jul; 289(27):19053-66. PubMed ID: 24860107
[TBL] [Abstract][Full Text] [Related]
14. Cytosolic components are required for proteasomal degradation of newly synthesized apolipoprotein B in permeabilized HepG2 cells.
Sakata N; Stoops JD; Dixon JL
J Biol Chem; 1999 Jun; 274(24):17068-74. PubMed ID: 10358059
[TBL] [Abstract][Full Text] [Related]
15. Identification of SVIP as an endogenous inhibitor of endoplasmic reticulum-associated degradation.
Ballar P; Zhong Y; Nagahama M; Tagaya M; Shen Y; Fang S
J Biol Chem; 2007 Nov; 282(47):33908-14. PubMed ID: 17872946
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin receptors and ERAD: a network of pathways to the proteasome.
Raasi S; Wolf DH
Semin Cell Dev Biol; 2007 Dec; 18(6):780-91. PubMed ID: 17942349
[TBL] [Abstract][Full Text] [Related]
17. p97 Inhibitor CB-5083 Blocks ERAD in Trypanosoma brucei.
Garrison P; Bangs JD
Mol Biochem Parasitol; 2020 Sep; 239():111313. PubMed ID: 32735998
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the p97-Ufd1-Npl4 complex in the regulated endoplasmic reticulum-associated degradation of inositol 1,4,5-trisphosphate receptors.
Alzayady KJ; Panning MM; Kelley GG; Wojcikiewicz RJ
J Biol Chem; 2005 Oct; 280(41):34530-7. PubMed ID: 16103111
[TBL] [Abstract][Full Text] [Related]
19. AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation.
Rabinovich E; Kerem A; Fröhlich KU; Diamant N; Bar-Nun S
Mol Cell Biol; 2002 Jan; 22(2):626-34. PubMed ID: 11756557
[TBL] [Abstract][Full Text] [Related]
20. Combined inhibition of p97 and the proteasome causes lethal disruption of the secretory apparatus in multiple myeloma cells.
Auner HW; Moody AM; Ward TH; Kraus M; Milan E; May P; Chaidos A; Driessen C; Cenci S; Dazzi F; Rahemtulla A; Apperley JF; Karadimitris A; Dillon N
PLoS One; 2013; 8(9):e74415. PubMed ID: 24069311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
